BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P3D
REFRESH-INTERVAL:P3D
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTART:20170427T180000Z
DTEND:20170427T193000Z
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:Brandwood Biomedical Luncheon
DESCRIPTION:p.p1 {margin: 0.0px 0.0px 0.0px 0.0px\; font: 12.0px Helvetica\; color: #454545}\n\nWANT TO REGISTER FOR HALF-DAY WORKSHOP: ISO 13485 Training Workshop\n\nClick Here!\n\n\n\nLuncheon Presentations  |  12:00pm - 1:30pm\n\nWhile Australia boasts a strong market for developing medical technology\, the landscape is complex and dynamic when it comes to Regulatory Affairs and Reimbursement. \n\n \n\nGrant Bennett\, Brandwood Biomedical's CEO\, will explore the Australian Regulatory Affairs market\; presenting on current trends and emerging issues that may affect organizations operating in the medical device industry.  Grant's presentation will focus on the Therapeutic Goods Administration (TGA)'s Medical Devices Review (MMDR)\, changes in the European Union (EU) and an overview of risk classification.\n\n\n\nAdditionally\, Sarah Griffin\, Brandwood Biomedical's Principal Reimbursement Consultant\, will take a look at Australia's medical device reimbursement system. Australia is a desirable and profitable market for medical devices   with no shortage of applicants. However\, there are complexities and challenges for the unwary and the process can be lengthy.  Sarah will discuss the latest developments in this market.
X-ALT-DESC;FMTTYPE=text/html:<style type="text/css">p.p1 {margin: 0.0px 0.0px 0.0px 0.0px\; font: 12.0px Helvetica\; color: #454545}\n</style>\n<p class="p1"><span style="font-size:24px\;"><span style="color:#990033\;"><strong style="color: rgb(69\, 69\, 69)\; font-family: Helvetica\; font-size: 12px\;">WANT TO REGISTER FOR&nbsp\;HALF-DAY WORKSHOP: ISO&nbsp\;13485 Training Workshop</strong></span><br />\n<a href="http://www.bioutah.org/events/details/iso-13485-training-workshop-including-luncheon-1246"><span style="color:#990033\;"><em><strong style="color: rgb(69\, 69\, 69)\; font-family: Helvetica\; font-size: 12px\;">Click Here!</strong></em></span></a></span><br />\n<br />\n<b>Luncheon Presentations&nbsp\; | &nbsp\;12:00pm&nbsp\;- 1:30pm</b></p>\n\n<p class="p1">While Australia boasts a strong market for developing medical technology\, the landscape is complex and dynamic when it comes to Regulatory Affairs and Reimbursement.&nbsp\;</p>\n\n<p class="p1">&nbsp\;</p>\n\n<p class="p1">Grant Bennett\, Brandwood Biomedical&rsquo\;s CEO\, will explore the Australian Regulatory Affairs market\; presenting on current trends and emerging issues that may affect organizations operating in the medical device industry. &nbsp\;Grant&rsquo\;s presentation will focus on the Therapeutic Goods Administration (TGA)&rsquo\;s Medical Devices Review (MMDR)\, changes in the European Union (EU) and an overview of risk classification.<br />\n<br />\nAdditionally\, Sarah Griffin\, Brandwood Biomedical&rsquo\;s Principal Reimbursement Consultant\, will take a look at Australia&#39\;s medical device reimbursement system. Australia is a desirable and profitable market for medical devices &ndash\; with no shortage of applicants. However\, there are complexities and challenges for the unwary and the process can be lengthy. &nbsp\;Sarah will discuss the latest developments in this market.</p>\n
LOCATION:p.p1 {margin: 0.0px 0.0px 0.0px 0.0px\; font: 12.0px Helvetica\; color: #454545} Edwards Lifesciences 12050 Lone Peak Pkwy Draper\, UT 84020
UID:e.9284.1265
SEQUENCE:3
DTSTAMP:20260409T212134Z
URL:http://bioutah.memberzone.com/events/details/brandwood-biomedical-luncheon-1265
END:VEVENT

END:VCALENDAR